| 000 | 01856 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516191532.0 | ||
| 264 | 0 | _c20140407 | |
| 008 | 201404s 0 0 eng d | ||
| 022 | _a1546-170X | ||
| 024 | 7 |
_a10.1038/nm.3441 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAblain, Julien | |
| 245 | 0 | 0 |
_aActivation of a promyelocytic leukemia-tumor protein 53 axis underlies acute promyelocytic leukemia cure. _h[electronic resource] |
| 260 |
_bNature medicine _cFeb 2014 |
||
| 300 |
_a167-74 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aArsenic Trioxide |
| 650 | 0 | 4 |
_aArsenicals _xpharmacology |
| 650 | 0 | 4 | _aComputational Biology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKaplan-Meier Estimate |
| 650 | 0 | 4 |
_aLeukemia, Promyelocytic, Acute _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicroarray Analysis |
| 650 | 0 | 4 |
_aNuclear Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOxides _xpharmacology |
| 650 | 0 | 4 | _aPromyelocytic Leukemia Protein |
| 650 | 0 | 4 |
_aProteolysis _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Retinoic Acid _xmetabolism |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xmetabolism |
| 650 | 0 | 4 | _aRetinoic Acid Receptor alpha |
| 650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
| 650 | 0 | 4 |
_aSignal Transduction _xphysiology |
| 650 | 0 | 4 |
_aTranscription Factors _xmetabolism |
| 650 | 0 | 4 |
_aTretinoin _xpharmacology |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xmetabolism |
| 700 | 1 | _aRice, Kim | |
| 700 | 1 | _aSoilihi, Hassane | |
| 700 | 1 | _ade Reynies, Aurélien | |
| 700 | 1 | _aMinucci, Saverio | |
| 700 | 1 | _ade Thé, Hugues | |
| 773 | 0 |
_tNature medicine _gvol. 20 _gno. 2 _gp. 167-74 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/nm.3441 _zAvailable from publisher's website |
| 999 |
_c23438164 _d23438164 |
||